|
|
|
|
Science Sparks @ ACTREC
|
 24 April 2023 |
Vol. No. 12; Issue No. 575 |
|
|
Publications
|
|
1. Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G, Purwar R (2023). Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option. Frontiers in Immunology. 14:1118246.
2. Gandhi VV, Gandhi KA, Goda JS, Kumbhare LB, Gota V, Kunwar A (2023). Post-radiation treatment of 3,3'-diselenodipropionic acid augments cell kill by modulating DNA repair and cell migration pathways in A549 cells. IUBMB Life.
3. Nayak P, Sinha S, Goda JS, Sahu A, Joshi K, Choudhry O Roy, Mhatre R, Mummudi N, Agarwal JP (2023). Computerized tomography-based first order tumor texture features in non-small cell lung carcinoma treated with concurrent chemoradiation: A simplistic and potential surrogate imaging marker for survival. Journal of Cancer Research and Therapeutics. 19(2): 366-375.
4. Harankhedkar S, Patkar N (2023). Molecular MRD assessment in acute myeloid leukemias. Indian Journal of Medical and Paediatric Oncology.
5. Kothari B, Parab P, Gulia S, Rath S, Gupta S (2023). Ribociclib-induced delayed dermatological reaction: Case report of a rare adverse effect and review of literature. Indian Journal of Medical and Paediatric Oncology.
6. Srinivasan S, Prasad M, Parambil BC, Shrimal A, Gollamudi VRM, Subramani V, Ramadwar M, Khanna N, Baheti AD, Gala K, Patil V, Laskar S, Qureshi S, Chinnaswamy G (2023). Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach. Pediatric Blood Cancer.
7. Badwe RA, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S, Kadayaprath G, Borthakur BB, Rao Thammineedi S, Pandya S, Balasubramanian S, Chitale PV, Neve R, Harris C, Srivastava A, Siddique S, Vanmali VJ, Dewade A, Gaikwad V, Gupta S (2023). Effect of peritumoral infiltration of local anesthetic before surgery on survival in early breast cancer. Journal of Clinical Oncology.
8. Budukh A, Bagal S, Thakur JS, Khanna D, Sancheti S, Banavali S (2023). Pediatric cancer burden in different regions of India: Analysis of published data from 33 population-based Cancer Registries. Indian Pediatrics.
Thesis
Mudassar Ali Khan. 2023. Structural Evaluation of Germline Missense Mutations Causing Hereditary Breast Cancer. (LIFE0909201604012) (Guide: Dr Ashok Varma)
|
|
|
|
|
Interesting Reads
|
|
Watanabe J, Muro K, Shitara K, Yamazaki K, Shiozawa M, Ohori H, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Hihara M, Soeda J, Misumi T, Yamamoto K, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 329(15):1271-1282, 2023.
|
|
|
Legends of Science
|
|
Kalpathi Ramakrishna Ramanathan
Kalpathi R Ramanathan obtained his DSc from the University of Madras in 1923. His primary fields of research were a molecular scattering of light and x-rays diffraction in liquids, gases and mixtures and anisotropy of molecules. His significant contribution was estimating the role of secondary and higher-order scattering in the twilight. Dr Ramanathan received the Padma Bhushan (1965); Padma Vibhushan (1976). He was the elected fellow of the Indian Academy of Sciences, Bangalore; Honorary Fellow Royal Meteorological Society, London; International Association of Meteorology; International Ozone Commission.
|
|
| |
|
Radhe Shyam Ambasht
Radhe Shyam Ambasht earned his PhD from the Banaras Hindu University. His major research was on species diversity, biomass productivity, nutrient cycling and plant adaptations in different kinds of ecosystems like grasslands, lakes and river embankments. His pioneering research was on soil conservation, water runoff and nutrient losses. He was elected fellow of the National Institute of Ecology; the National Academy of Sciences, Allahabad.
|
|
| |
|
|
|
|
Do You Know?
In 1992, Susan Knox used radiolabeled monoclonal antibodies to treat patients with lymphoma and solid tumors.
|
|
|
|
Cancer News
|
|
St Judes and ACTREC to launch 226-unit facility for children with cancer in Mumbai
|
|
18 April 2023, The CSR Journal
|
|
The facility aims to support and empower over 34,000 cancer-stricken families with quality education, shelter, nutrition, skill building, counselling, and transport facilities over a span of 20 years. Dr Sudeep Gupta, Director, ACTREC, said, ” The TMC – St Judes Childcare Centre will be crucial to delivering high-quality care to children with cancer and achieving high cure rates.”...
|
|
|
| |
|
Preoperative Peritumoral Infiltration of Local Anesthetic in Patients With Early Breast Cancer: Effect on Survival
|
|
19 April 2023, The ASCO Post
|
|
In an Indian trial reported in the Journal of Clinical Oncology, Badwe et al found that peritumoral infiltration of local anesthetic prior to surgery in patients with early breast cancer was associated with improved disease-free and overall survival... |
|
|
| |
|
Enzyme lights dual fires to promote cancer
|
|
19 April 2023, Nature
|
|
Tumours with certain cancer-driving mutations are difficult to treat. A discovery that one enzyme both controls proliferation and suppresses anticancer immune defences presages the exploration of new cancer-therapy strategies...
|
|
|
| |
|
|
|
|
|
|
2023 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
